SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 31, 2002
CardioGenesis Corporation
California | 000-28288 | 77-0223740 | ||
|
||||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||
26632 Towne Centre Drive, Suite 320, Foothill Ranch, California |
92610 |
|||
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (714) 649-5000
Item 5. Other Events | ||||||||
Item 7. Financial Information, Pro Forma Financial Information and Exhibits | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Item 5. Other Events
On December 31, 2002, the Registrant issued a press release titled CardioGenesis Corporation to Appeal Nasdaq Delisting Notice, a copy of which is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Item 7. Financial Information, Pro Forma Financial Information and Exhibits
(a) Not applicable.
(b) Not applicable.
(c) Exhibits:
Pursuant to General Instruction F of Form 8-K, the following documents are incorporated by reference herein and attached as exhibits hereto:
Exhibit | Description | |
99.1 | Press release of CardioGenesis Corporation dated December 31, 2002, titled CardioGenesis Corporation to Appeal Nasdaq Delisting Notice. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.
CARDIOGENESIS CORPORATION | ||||
Date: January 3, 2003 | By: | /s/ DARRELL F. ECKSTEIN | ||
Darrell F. Eckstein President, Chief Operating Officer and Acting Chief Financial Officer |
EXHIBIT INDEX
Exhibit | Description | |
99.1 | Press release of CardioGenesis Corporation dated December 31, 2002, titled CardioGenesis Corporation to Appeal Nasdaq Delisting Notice. |